Tel/platelet-derived growth factor receptor β activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle

Blood

Volumn 99, Issue 5, 2002, Pages 1758-1765

  Dierov, Jamil ^a   Xu, Qing ^a   Dierova, Raia ^a   Carroll, Martin ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BRB 2 3   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HYBRID PROTEIN; IMATINIB; INTERLEUKIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 5; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; LEUKEMOGENESIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036493405     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.5.1758     Document Type: Article

References (46)

1. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about
2. Chronic myeloid leukemia
3. The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase
4. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: Roles for phosphatidylinositol 3-kinase and Raf
5. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
6. Transformation of hematopoietic cells by BCR/ABL requires activation of a Pl-3k/Akt-dependent pathway
7. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
8. TEL-AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
9. The novel activation of ABL by fusion to an ets-related gene, TEL
10. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like gene TEL on 12p13 to the MN1 gene on 22q11
11. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways
12. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein
13. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein
14. Tel induces a G1 arrest and suppresses Ras-induced transformation
15. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Etsrelated factor TEL
16. Platelet-derived growth factor receptor signals
17. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
18. Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDGFRbeta)
19. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway
20. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: A common mechanism for transformation by tyrosine kinase fusion proteins
21. Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction
22. Structure and function of phosphoinositide 3-kinases
23. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
24. Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling
25. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
26. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase
27. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo
28. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line
29. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a novel tyrosine protein kinase inhibitor of the 2-phenylaminopyrimidine class
30. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
31. Identification of a novel inhibitor of mitogen-activated protein kinase
32. Inhibition of mitogen-activated protein kinase blocks T cell proliferation but does not induce or prevent energy
33. High-titer retroviral vectors for efficient transduction of functional genes into murine hematopoietic stem cells
34. Interleukin 3-dependent survival by the Akt protein kinase
35. Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells
36. Akt phosphoryla tion of BAD couples survival signals to the cellintrinsic death machinery
37. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation
38. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells
39. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
40. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1)
41. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway
42. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway
43. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5
44. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
45. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis
46. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway